M&G Investment Management’s AbbVie ABBV Stock Holding History

M&G Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$22.4M	Sell	144,740 -50,559	-26%	-$7.37M	0.08%	115
2023 Q3	$29.1M	Sell	195,299 -80,605	-29%	-$11.8M	0.13%	103
2023 Q2	$37.2M	Buy	275,904 +39,620	+17%	+$5.81M	0.15%	92
2023 Q1	$37.6M	Sell	236,284 -68,485	-22%	-$10.5M	0.18%	94
2022 Q4	$49.4M	Sell	304,769 -45,635	-13%	-$7M	0.24%	78
2022 Q3	$47K	Sell	350,404 -2,356	-0.7%	-$338K	0.27%	81
2022 Q2	$54K	Sell	352,760 -13,845	-4%	-$2.12M	0.32%	83
2022 Q1	$59.4K	Sell	366,605 -72,640	-17%	-$10.6M	0.12%	83
2021 Q4	$59.3K	Sell	439,245 -593,344	-57%	-$70.1M	0.15%	78
2021 Q3	$112K	Buy	1,032,589 +156,724	+18%	+$17.9M	0.27%	51
2021 Q2	$99K	Buy	875,865 +333,318	+61%	+$37.5M	0.25%	55
2021 Q1	$58.6K	Sell	542,547 -57,444	-10%	-$6.14M	0.18%	61
2020 Q4	$64.2K	Buy	599,991 +25,628	+4%	+$2.46M	0.4%	56
2020 Q3	$50.5M	Sell	574,363 -882	-0.2%	-$83K	0.5%	59
2020 Q2	$56.4M	Buy	575,245 +209,873	+57%	+$18.5M	0.6%	47
2020 Q1	$27.8M	Buy	365,372 +78,367	+27%	+$6.68M	0.34%	74
2019 Q4	$25.5M	Buy	+287,005	New	+$23.8M	0.23%	96

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

M&G Investment Management's ABBV Position: Q4 2023 in Review

M&G Investment Management reduced its AbbVie (ABBV) stake by 26% in Q4 2023, selling an estimated $7.37M and leaving 144,740 shares worth $22.4M. The position accounts for 0.08% of the portfolio, ranked #115.

M&G Investment Management first reported a position in ABBV in Q4 2019 and has held it in 17 quarters since. The position peaked at $56.4M in Q2 2020. 3,322 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.

M&G Investment Management held 144,740 shares of AbbVie worth $22.4M as of Q4 2023.
M&G Investment Management sold 50,559 AbbVie shares in Q4 2023, an estimated $7.37M.
AbbVie made up 0.08% of M&G Investment Management's portfolio in Q4 2023, its #115 holding.
M&G Investment Management first reported a position in AbbVie in Q4 2019 and has held it in 17 quarters since.
M&G Investment Management's AbbVie position peaked at $56.4M in Q2 2020.
3,322 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.

Based on M&G Investment Management's 13F filing for Q4 2023, filed 8 Feb 2024.